Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | FDPS | P14324 | 2/20 | 0.35 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.32 |
| ▸ | MVD | P53602 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | GGH | Q92820 | 1/20 | 0.32 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP3 | P08254 | 1/20 | 0.31 |
| ▸ | MMP8 | P22894 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1463097 | 0.86 | MEN1 (0.34) | MEN1LMNAHPGDTSHRBLM | |
| SCHEMBL10716346 | 0.84 | FOLH1 (0.34) | MEN1LMNAHPGDTSHRBLM | |
| SCHEMBL10716340 | 0.84 | FOLH1 (0.34) | MEN1LMNAHPGDTSHRBLM | |
| SCHEMBL9833755 | 0.82 | FDPS (0.38) | MEN1LMNAHPGDTSHRBLM | |
| SCHEMBL10409147 | 0.81 | MVD (0.32) | MVD | |
| SCHEMBL10482435 | 0.81 | MVD (0.32) | MEN1LMNAHPGDTSHRBLM | |
| SCHEMBL29420575 | 0.80 | FDPS (0.33) | MEN1LMNAHPGDTSHRBLM | |
| SCHEMBL156073 | 0.79 | TDP1 (0.41) | LMNATSHRBLMTDP1 | |
| SCHEMBL10482425 | 0.79 | FDPS (0.36) | MEN1LMNAHPGDTSHRBLM | |
| SCHEMBL3838114 | 0.78 | TDP1 (0.39) | MEN1LMNAHPGDTSHRBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0221043-B1 | PROCESS FOR THE PREPARATION OF N-SUBSTITUTED AMINOMETHYLPHOSPHONIC ACIDS | Monsanto Company (US) | 1991-09-11 | — | — | EP | claimed |
| US-4804499-A | Process for the preparation of N-substituted aminomethylphosphonic acids | MONSANTO COMPANY (US) | 1989-02-14 | — | — | US | claimed |
| EP-0221043-A1 | Process for the preparation of N-substituted aminomethylphosphonic acids | Monsanto Company (US) | 1987-05-06 | — | — | EP | claimed |
| US-4657705-A | Process for the preparation of N-substituted aminomethylphosphonic acids | MONSANTO COMPANY (US) | 1987-04-14 | — | — | US | claimed |
| EP-0216744-A2 | The compound 1,4-diisopropyl-2,5-diketopiperazine | Monsanto Company (US) | 1987-04-01 | — | — | EP | claimed |
| EP-0216745-A1 | Process for the preparation of N-substituted aminomethylphosphonic acids | Monsanto Company (US) | 1987-04-01 | — | — | EP | claimed |
| US-7750180-B2 | Process for the preparation of N-phosphonomethylglycine and derivatives thereof | MONSANTO TECHNOLOGY LLC (US) | 2010-07-06 | — | — | US | disclosed |
| US-7297657-B2 | Process for the preparation of N-(phosphonomethyl)glycine by oxidizing N-substituted N-(phosphonomethyl)glycine | MONSANTO TECHNOLOGY LLC (US) | 2007-11-20 | — | — | US | disclosed |
| EP-1716923-A1 | Oxidation catalyst for making glyphosate | Monsanto Technology, LLC (US) | 2006-11-02 | — | — | EP | disclosed |
| EP-1664068-A2 | PROCESS FOR THE PREPARATION OF N-PHOSPHONO-METHYLGLYCINE AND DERIVATIVES THEREOF | Monsanto Technology, LLC (US) | 2006-06-07 | — | — | EP | disclosed |
| EP-1062221-B1 | PROCESS FOR MAKING GLYPHOSATE BY OXIDIZING N-SUBSTITUTED GLYPHOSATES | MONSANTO TECHNOLOGY LLC (US) | 2006-05-10 | — | — | EP | disclosed |
| EP-1520857-A1 | Process for the preparation of N-(phosphonomethyl) glycine by oxidizing N-substituted N-(phosphonomethyl) glycine | Monsanto Technology LLC (US) | 2005-04-06 | — | — | EP | disclosed |
| US-20050054871-A1 | Process for the preparation of N-phosphonomethylglycine and derivatives thereof | MONSANTO TECHNOLOGY LLC | 2005-03-10 | — | — | US | disclosed |
| EP-0186648-A1 | Process for the preparation of glyphosate and glyphosate derivatives | Monsanto Company (US) | 1986-07-02 | — | — | EP | disclosed |
| EP-0186647-A1 | Process for preparing glyphosate and glyphosate derivatives | Monsanto Company (US) | 1986-07-02 | — | — | EP | disclosed |
| US-4568432-A | REACTING OXO-AMINES WITH CARBONYLPHOSPHONIC COMPOUND, THEN REDUCTION | MONSANTO COMPANY (US) | 1986-02-04 | — | — | US | disclosed |
| US-4471131-A | POST EMERGENCE HERBICIDES | MONSANTO COMPANY (US) | 1984-09-11 | — | — | US | disclosed |
| US-4131448-A | HERBICIDE | MONSANTO COMPANY (US) | 1978-12-26 | — | — | US | disclosed |
| US-4130412-A | HERBICIDE | MONSANTO COMPANY (US) | 1978-12-19 | — | — | US | disclosed |
| US-4062669-A | N-Organo-N-phosphonomethylglycine-N-oxides and plant growth regulant and phytotoxicant compositions containing same | MONSANTO COMPANY (US) | 1977-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050054871-A1 | Process for the preparation of N-phosphonomethylglycine and derivatives thereof | PHOSPHO1, GNE, MPHOSPH6 | MEN1 1141/4885LMNA 1967/4885HPGD 648/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.